Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: Role of CD62L

Immunologic Research

Volumn 57, Issue 1-3, 2013, Pages 23-33

  Díaz Montero, C Marcela ^a   Zidan, Abdel Aziz ^b   Pallin, Maria F ^c   Anagnostopoulos, Vasileios ^c   Salem, Mohamed L ^b   Wieder, Eric ^c   Komanduri, Krishna ^c   Montero, Alberto J ^d   Lichtenheld, Mathias G ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Tanta University   (Egypt)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Adoptive immunotherapy; CD62L; CD8 T cells; Cyclophosphamide; Melanoma; Pmel

Indexed keywords

CYCLOPHOSPHAMIDE; INTERLEUKIN 12; L SELECTIN;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL THERAPY; CONTROLLED STUDY; EX VIVO STUDY; IMMUNOBIOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOID ORGAN; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; GP100 MELANOMA ANTIGEN; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; L-SELECTIN; LYMPH NODES; LYMPHOPENIA; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; TUMOR BURDEN;

EID: 84891495309     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8456-1     Document Type: Article

References (36)

1. Starnes CO. Coley's toxins in perspective. Nature. 1992;357(6373):11-2. doi: 10.1038/357011a0.
2. Wolchok JD, Hodi FS, Weber JS, Allison JP, Urba WJ, Robert C, et al. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann N Y Acad Sci. 2013;1291:1-13. doi: 10.1111/nyas.12180.
3. Romero P, Cerottini JC, Speiser DE the human T cell response to melanoma antigens. Adv Immunol. 2006;92:187-224. doi: 10.1016/S0065-2776(06)92005-7.
4. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17(13):4550-7. doi: 10.1158/1078-0432.CCR-11-0116.
5. Rosenberg SA. Raising the bar: the curative potential of human cancer immunotherapy. Sci Transl Med. 2012;4(127):127ps8. doi: 10.1126/scitranslmed. 3003634.
6. Diaz-Montero CM, El Naggar S, Al Khami A, El Naggar R, Montero AJ, Cole DJ, et al. Priming of naive CD8 + T cells in the presence of IL-12 selectively enhances the survival of CD8(+)CD62L (hi) cells and results in superior anti-tumor activity in a tolerogenic murine model. Cancer Immunol Immunother. 2008;57(4):563-72.
7. Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K, et al. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med. 1998;188(2):277-86.
8. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8 + T cells. J Exp Med. 2003;198(4):569-80.
9. Schumacher TN. T-cell-receptor gene therapy. Nat Rev Immunol. 2002;2(7):512-9. doi: 10.1038/nri841.
10. Riddell SR, Jensen MC, June CH. Chimeric antigen receptor-modified T cells: clinical translation in stem cell transplantation and beyond. Biol Blood Marrow Transpl. 2013;19(1 Suppl):S2-5. doi: 10.1016/j.bbmt.2012.10.021.
11. Diaz-Montero CM, Naga O, Zidan AA, Salem ML, Pallin M, Parmigiani A, et al. Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory. Am J Cancer Res. 2011;1(7):882-96.
12. Gattinoni L, Klebanoff CA, Palmer DC, Wrzesinski C, Kerstann K, Yu Z, et al. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8 + T cells. J Clin Invest. 2005;115(6):1616-26.
13. Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, et al. Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA. 2005;102(27):9571-6.
14. Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol. 2005;17(3):326-32.
15. Arbones ML, Ord DC, Ley K, Ratech H, Maynard-Curry C, Otten G, et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity. 1994;1(4):247-60.
16. Xu J, Grewal IS, Geba GP, Flavell RA. Impaired primary T cell responses in L-selectin-deficient mice. J Exp Med. 1996;183(2):589-98.
17. Schuster K, Gadiot J, Andreesen R, Mackensen A, Gajewski TF, Blank C. Homeostatic proliferation of naive CD8 + T cells depends on CD62L/L-selectin- mediated homing to peripheral LN. Eur J Immunol. 2009;39(11):2981-90. doi: 10.1002/eji.200939330.
18. Borsig L, Wong R, Hynes RO, Varki NM, Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA. 2002;99(4):2193-8. doi: 10.1073/pnas.261704098.
19. Giblin PA, Hwang ST, Katsumoto TR, Rosen SD. Ligation of L-selectin on T lymphocytes activates beta1 integrins and promotes adhesion to fibronectin. J Immunol. 1997;159(7):3498-507.
20. Steeber DA, Engel P, Miller AS, Sheetz MP, Tedder TF. Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes. J Immunol. 1997;159(2):952-63.
21. Subramanian H, Grailer JJ, Ohlrich KC, Rymaszewski AL, Loppnow JJ, Kodera M, et al. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. J Immunol. 2012;188(7):3223-36. doi: 10.4049/jimmunol.1101032.
22. Dell'Angelica EC. Melanosome biogenesis: shedding light on the origin of an obscure organelle. Trends Cell Biol. 2003;13(10):503-6.
23. Steeber DA, Green NE, Sato S, Tedder TF. Lymphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system. J Immunol. 1996;157(3):1096-106.
24. Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, Rosenberg SA, et al. Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother. 2005;28(3):258-67.
25. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (New York, NY). 1994;264(5159):703-7.
26. Sprent J, Surh CD. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol. 2011;12(6):478-84.
27. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4(12):1191-8. doi: 10.1038/ni1009.
28. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res. 2011;17(13):4550-7. doi: 10.1158/1078-0432.CCR-11-0116.
29. Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer. 2012;12(10):671-84. doi: 10.1038/nrc3322.
30. Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, et al. Wnt signaling arrests effector T cell differentiation and generates CD8 + memory stem cells. Nat Med. 2009;15(7):808-13.
31. Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol. 2011;12(3):189-97. doi: 10.1038/nrm3068.
32. Gahmberg CG, Fagerholm SC, Nurmi SM, Chavakis T, Marchesan S, Gronholm M. Regulation of integrin activity and signalling. Biochim Biophys Acta. 2009;1790(6):431-44. doi: 10.1016/j.bbagen.2009.03.007.
33. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity. 2008;29(6):848-62. doi: 10.1016/j.immuni.2008.11.002.
34. Ito D, Back TC, Shakhov AN, Wiltrout RH, Nedospasov SA. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment. J Immunol. 1999;163(5):2809-15.
35. Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8 + T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest. 2008;118(1):294-305. doi: 10.1172/JCI32103.
36. Stemberger C, Huster KM, Koffler M, Anderl F, Schiemann M, Wagner H, et al. A single naive CD8 + T cell precursor can develop into diverse effector and memory subsets. Immunity. 2007;27(6):985-97. doi: 10.1016/j.immuni.2007.10.012.